Tsai Shih-Meng

Get in Touch

• Tel: +886-7-312-1101 ext. #2774
• Fax: +886-7-312-1101 ext. #5345
• Email: tsaism@kmu.edu.tw

Education

Present post and experience

Field of research

1. Biostatistics
2. Epidemiology

Publication

in 7 years

1. Su-Chen Lee, Ming-Feng Hou, Pei-Chen Hsieh, Szu-Hsien Wu, Linda Ann Hou, Hsu Ma, Shin-Meng Tsai*, Li-Yu Tsai*: A case–control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan. Clin Biochem 2008 41(3): 121-125 (SCI) IF：；MEDICAL LABORATORY TECHNOLOGY 11/32 = 34.38%
2. Yang-Ming Tseng, Yi-Ru Jin, Ing-Jun Chen, Fong-Dee Huang, Szu-Hsien Wu, Hsu Ma, Sheng-Yi Chen, Li-Yu Tsai*, Shih-Meng Tsai*, Jang-Hwa Lee*: Roles of the genetic variation of alcohol-metabolizing enzymes on biomarkers in trauma patients with excessive alcohol intake at emergency department. Clin Chim Acta 2008 March 389 (1-2): 14-18. (SCI) IF：；MEDICAL LABORATORY TECHNOLOGY 6/32 = 18.75%
3. Yang-Ming Tseng, Sheng-Yi Chen, Chien-Hung Chen, Yi-Ru Jin, Shih-Meng Tsai, Ing-Jun Chen, Jang-Hwa Lee, Chzng-Cheng Chiu, Li-Yu Tsai *: Effects of Alcohol-Induced Human Peripheral Blood Mononuclear Cell (PBMC) Pretreated Whey Protein Concentrate (WPC) on Oxidative Damage. J Agr Food Chem 2008; 56 (17): 8141-8147 (SCI) IF: 2.823; AGRICULTURE, MULTIDISCIPLINARY 3/57 = 5.26%
4. Shih-Meng Tsai, Chiou-Ya Lin, Szu-Hsien Wu, Lisa Ann Hou, Hsu Ma, Li-Yu Tsai*, Ming-Feng Hou*: Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms. Clin Chim Acta 2009 Mar; 404 (2): 160-165 (SCI) IF：；MEDICAL LABORATORY TECHNOLOGY 6/32 = 18.75%
5. Shih-Ming Tsai, Shu-Kai Lin, King-The Lee, Szu-Hsien Wu, Jen-Kuei Hsiao, Jung-Chih Huang, Hsu Ma, Szu-Hwa Wu, Li-Yu Tsai*: Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. Ann Clin Biochem 2009 Sep; 46(5): 394-400 (SCI) IF: 2.170 ; MEDICAL LABORATORY TECHNOLOGY 9/32 = 28.13%
6. Yang-Ming Tseng, Shih-Meng Tsai, Sheng-Yi Chen, Chun-Chin Lin, Yi-Ru Jin, Wei-Hao Yeh, Yi-Ru Wu, Ing-Jun Chen, Jang-Hwa Lee, Li-Yu Tsai*: Roles of the Genetic Polymorphisms of Alcohol-metabolizing Enzymes on the Immunology in High-risk Drinkers. Toxicol Sci 2009 Sep; 111(2): 267-276 (SCI) IF: 4.652; TOXICOLOGY 9/83 = 10.84%
7. Chung-Yu Chang, Yu-Ti Fang, Shih-Meng Tsai, Lin-Li Chang, Wen-Liang Yu*. Characterization of class 1 integrons and gene cassettes in clinical isolates of Klebsiella pneumoniae from Taiwan. Diagn Microbiol Infect Dis 2009;65: 214–216 (SCI) IF: 2.528; Microbiology 53/112 = 47.32%
8. Tin-Hsin Hsiao, Shih-Meng Tsai, Szu-Ting Chou, Jing-Yun Pan, Yu-Chuan Tseng, Hong-Po Chang, Hong-Sen Chen*. Sex determination using discriminant function analysis in children and adolescents: A lateral cephalometric study. Int J Legal Med 2010;124:155–160 (SCI) IF:2.597; Medicine Legal 3/16 = 18.75%
9. Szu-Hsien Wu, Shih-Meng Tsai, Ka-Wo Lee, Jian-Hong Chen, Hsu Ma, Li-Yu Tsai*. Coexistence of the increasing oxidative stress and the clinical severity of patients with oral cavity cancer. JTSPS 2010;19:104-113.
10. ChenWu1, Ping-Ho Chen, Chien-JenWang, Deng-ChyangWu, Shih-Meng Tsai, Mu-Rong Chao, Bai-Hsiun Chen, Hei-Hwa Lee, Chien-Hung Lee, Ying-Chin Ko*. Quantification of Blood Betel Quid Alkaloids and Urinary 8-Hydroxydeoxyguanosine in Humans and their Association with Betel Chewing Habits. Journal of Analytical Toxicology, 2010;34: 325-31. (SCI) IF: 2.627; CHEMISTRY, ANALYTICAL 27/76 = 35.53%
11. Szu-Hsien Wu, Ka-Wo Lee, Chien-Hung Chen, Chun-Chin Lin, Yang-Ming Tseng, Hsu Ma, Shih-Ming Tsai*, Li-Yu Tsai*. Epistasis of oxidative stress-related enzyme genes on modulating the risks in oral cavity cancer. Clin Chim Acta 2010;411:1705-1710 (SCI) IF：；MEDICAL LABORATORY TECHNOLOGY 6/32 = 18.75%
12. Yang-Ming Tseng, Shih-Meng Tsai, Wen-Shan Lin, Zih-Ru Huang, Chun-Chin Lin, Wei-Hao Yeh, Yi-Ru Wu, Li-Yu Tsai*: Effects of whey protein concentrate (WPC) on the distributions of lymphocyte subpopulations in rats with excessive alcohol intake. J Agr Food Chem 2010;58:12729-12734 (SCI) IF: 2.906; AGRICULTURE, MULTIDISCIPLINARY 1/57 = 1.75%
13. Shih-Meng Tsai, Ming-Feng Hou, Szu-Hsien Wu, Bao-Wen Hu, Sheau-Fang Yang, Wan-Tzu Chen, Chee-Yin Chai, Hsu Ma, Li-Yu Tsai*: Expression of manganese superoxide dismutase in patients with breast cancer. Kaohsiung J Med Sci 2011:27 ; 167-172 (SCI) IF: 0.502; MEDICINE, RESEARCH & EXPERIMENTAL 104/121=85.95%
14. Su-Chen Lee, Li-Hsuan Wang, Shih-Meng Tsai, Hung-Yao Fang, Li-Yu Tsai*: Effects of the Hb E, Hb H and Hb G-Taichung variants on HbA1c values by the Bio-Rad VariantTM II Turbo analyzer Clin Biochem 2011: 44; 1338–1342(SCI) IF: 2.450; MEDICAL LABORATORY TECHNOLOGY 8/32 =25.0%
15. Shih-Meng Tsai, Szu-Hsien Wu, Ming-Feng Hou, Yueh-Ling Chen, Hsu Ma, Li-Yu Tsai*: Oxidative stress-related enzyme gene polymorphisms and susceptibility to breast cancer in non-smoking, non-alcohol consuming Taiwanese women. Ann Clin Biochem 2012 Mar;49(Pt 2):152-8. Epub 2011 Nov 30 (SCI) IF: 1.922 ; MEDICAL LABORATORY TECHNOLOGY 12/32 = 37.5%
16. Yang-Ming Tseng, Shih-Meng Tsai, Chun-Chin Lin, Yi-Ru Jin, Wei-Hao Yeh, Jen-Kuei Hsiao, Chi-Fen Chen, Wu-Hsiang Lan, Li-Yu Tsai*: Oxidative Stress-related Enzyme Polymorphisms Associated with the Immunological Biomarkers Levels in Heavy Drinkers in Taiwan. J CLIN LAB ANAL 2013; 27: 494-503 (SCI) IF: 1.356; MEDICAL LABORATORY TECHNOLOGY 18/32 = 56.25%
17. Shyh-Shin Chiou, Chao-Jung Tsao, Shih-Meng Tsai, Ye-Ru Wu, Yu-Mei Liao, Pei-Chin Lin, Li-Yu Tsai*: Metabolic Pathways Related to Oxidative Stress in Patients with Hemoglobin H Disease and Iron Overload. J CLIN LAB ANAL 2014;28:261-268 (SCI) IF: 1.356; MEDICAL LABORATORY TECHNOLOGY 18/32 = 56.25%
18. Shih-Meng Tsai, Szu-Hsien Wu, Ming-Feng Hou, Hlio-Han Yang and Li-Yu Tsai*:The immune regulator VTCN1 gene polymorphisms and its impact on susceptibility to breast cance. J CLIN LAB ANAL 2014; 00: 1-7 (SCI) IF: 1.356; MEDICAL LABORATORY TECHNOLOGY 18/32 = 56.25%
19. Su-Chen Lee, Shih-Meng Tsai, Ming-Feng Hou, Li-Ying Tien, Szu-Hsien Wu, Lisa Ann Hou, Joseph M Tsai, Li-Yu Tsai*: Increased IGF-I/IGFBP-3 ratios in postmenopausal Taiwanese with breast cancer, irrespective of ER and PR statuses and HER2 expression in a case-control study. J CLIN LAB ANAL 2014 (SCI) (accept) IF: 1.356; MEDICAL LABORATORY TECHNOLOGY 18/32 = 56.25%